Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01803 |
| Species: | Homo sapiens |
| Position : | chr19:18373265-18374622 |
| Year: | 2026 |
| Title: | Functional characterization of the GWAS lead SNP rs888663 and effects of GDF15 SNPs on GDF15 levels in gestational hypertension and preeclampsia |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 41793551 |
| MONDO: | |
| Tissue: | Skin |
| Tissue Ontology ID: | UBERON:0000014 |
| Cell Source: | Human hypertrophic scar fibroblasts (HSFs) |
| CVCL ID: | |
| Cell Type: | fibroblast |
| Cell Ontology ID: | CL:0000057 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | |
| Low Throughput Method: | Luciferase Reporter Assay |
| Target gene : | GDF15 |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01853 | chr19:18373265-18374622 | Adrenal gland | neuroblastoma cell | neuroblastoma |